Auditor, Rosa M.
HRN: 27-87-18 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/28/2025
CEFUROXIME 500MG (TAB)
09/28/2025
10/04/2025
PO
500mg
BID
NSVD; Thickly MSAF
Checking Final Appropriateness
09/28/2025
METRONIDAZOLE 500MG (TAB)
09/28/2025
10/04/2025
PO
500mg
TID
NSVD; Thickly MSAF
Checking Final Appropriateness